Therapeutic drug monitoring to optimise treatment of inflammatory bowel disease with tumour necrosis factor inhibitors

Y Wu - 2021 - unsworks.unsw.edu.au
Abstract INTRODUCTION Anti-Tumour Necrosis Factor-α inhibitors, infliximab (IFX) and
adalimumab (ADA) have proven clinical efficacy in inflammatory bowel disease (IBD) …
相关文章

Therapeutic drug monitoring to optimise treatment of inflammatory bowel disease with tumour necrosis factor inhibitors

Y Wu - 2021 - unsworks.unsw.edu.au
dc. description. abstract INTRODUCTION Anti-Tumour Necrosis Factor-α inhibitors,
infliximab (IFX) and adalimumab (ADA) have proven clinical efficacy in inflammatory bowel …